Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03934476
Other study ID # OU-PdF-GACR-LCHF diet
Secondary ID 18-08358S
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date December 31, 2020

Study information

Verified date January 2020
Source University of Ostrava
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to investigate the long-term effects of the ketogenic diet and exercise (including interactions) on health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals.


Description:

Intentional nutritional ketosis induced by the low carbohydrate diet is an intensively discussed topic of many scientific as well as non-scientific discussions throughout the areas of healthy living, the sports sciences and often used now for the prevention and treatment of chronic diseases. It has been demonstrated that long-term low-carbohydrate diet is more effective for weight loss and cardiovascular and metabolic risk factor reduction than a low-fat diet. In light of conflicting theories of best practice surrounding a polarized topic that impacts human health and daily work performance, the primary aim of this research project is to examine how low-carbohydrate ketogenic diets affect health markers, exercise performance and wellbeing outcomes in sedentary overweight individuals. Each study subject will be randomized into one of the four arms of the study and will undergo a 12-week intervention, with the exception of the study subjects in the control group, who will undergo no intervention for the period of 12 weeks. The project outcomes are of immense importance for the investigator's global human health, focus on a unique holistic perspective and have the potential to contribute towards much-needed adjustments in public health recommendations.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 31, 2020
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - BMI 25.00 - 40.00 kg/m2 - non-smokers - non-excessive alcohol intake (self-reported, = to 2 drinks/day for men or =1 drink/day for women) - willing to accept random assignment - low active individuals over the last 1 year, i.e. no specific sports training or regular exercise (up to once a week) and self-reported physical activity < 150 min/week (IPAQ) - no evidence of liver, renal, metabolic, and cardiopulmonary disease and dis-eases contraindicating physical activity, no cancer, no psychiatric illness - Physical Activity Readiness Questionnaire (PAR-Q) pass - body weight stable for the last 2 months and not actively on a weight loss plan - prediabetes state allowed (impaired fasting glucose level, i.e. 5.6 - 6.9 mmol/l; HbA1c 5.7 - 6.4 %) Exclusion Criteria: - pregnancy, lactation - any specific diet (e.g. vegetarian) - use of hypoglycemic, lipid-lowering, antihypertensive, psychiatric medications or medications known to affect body weight or energy expenditure; any medication not noted allowed if the individual had been stable while taking such medication for at least 3 months prior to baseline data collection

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Ketogenic diet
The study subjects randomized for this intervention will observe the ketogenic diet, as prescribed by the protocol.
Exercise HIIT
The study subjects randomized for this intervention will observe the HIIT exercise programme, as prescribed by the protocol.

Locations

Country Name City State
Czechia University of Ostrava Ostrava Moravian-Silesian Region

Sponsors (1)

Lead Sponsor Collaborator
University of Ostrava

Country where clinical trial is conducted

Czechia, 

References & Publications (1)

Cipryan L, Plews DJ, Ferretti A, Maffetone PB, Laursen PB. Effects of a 4-Week Very Low-Carbohydrate Diet on High-Intensity Interval Training Responses. J Sports Sci Med. 2018 May 14;17(2):259-268. eCollection 2018 Jun. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the time to exhaustion All study subjects will undergo the Graded Exercise Test, with measuring of the time to exhaustion in minutes. 12 weeks (baseline + every four weeks)
Primary Change in cardiorespiratory variables - oxygen consumption All study subjects will undergo the Graded Exercise Test, with measuring of the oxygen consumption (L/min). 12 weeks (baseline + every four weeks)
Primary Change in cardiorespiratory variables - heart rate All study subjects will undergo the Graded Exercise Test, with measuring of the heart rate (beats per minute). 12 weeks (baseline + every four weeks)
Secondary Biochemical analysis - capillary blood All study subjects will undergo biochemical analysis of capillary blood - ßHB and fasting glukose in mmol/L. 12 weeks (2 times/week)
Secondary Biochemical analysis - venous blood All study subjects will undergo biochemical analysis of venous blood - oxidative stress, inflammation, total CHO, HDL, LDL, TG, FFA, GL, homocysteine, measured in mmol/L. 12 weeks (2 times/week)
Secondary Biochemical analysis - venous blood All study subjects will undergo biochemical analysis of venous blood - HBA1c in mmol/mol. 12 weeks (2 times/week)
Secondary Anthropometrics - body height All study subjects will undergo anthropometric assessment of the body height, measured in cm. 12 weeks (baseline + every four weeks)
Secondary Anthropometrics - body weight All study subjects will undergo anthropometric assessment of the body weight, measured in kg. 12 weeks (baseline + every four weeks)
Secondary Anthropometrics - waist circumference All study subjects will undergo anthropometric assessment of the waist circumference, measured in cm. 12 weeks (baseline + every four weeks)
Secondary Anthropometrics - DXA All study subjects will undergo anthropometric assessment of DXA - total abdominal fat, measured in kg. 12 weeks (baseline + outcome)
Secondary InBody (bioimpedance) All study subjects will undergo antrhropometric assessment of bioimpedance using the InBody device showing the percentage of water and fat in the organism, measured in % of total body weight. 12 weeks (baseline + every four weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2